首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
【2h】

Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial

机译:成人伴和不伴鼻息肉的慢性鼻-鼻窦炎的克拉霉素和内窥镜鼻窦手术:MACRO随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundChronic rhinosinusitis (CRS) is a common source of ill health; 11% of UK adults reported CRS symptoms in a worldwide population study. Guidelines are conflicting regarding whether antibiotics should be included in primary medical management, reflecting the lack of evidence in systematic reviews. Insufficient evidence to inform the role of surgery contributes to a fivefold variation in UK intervention rates. The objective of this trial is to establish the comparative effectiveness of endoscopic sinus surgery (ESS) or a prolonged course of antibiotics (clarithromycin) in adult patients with CRS in terms of symptomatic improvement and costs to the National Health Service compared with standard medical care (intranasal medication) at 6 months.
机译:背景慢性鼻-鼻窦炎(CRS)是一种不健康的常见病因。在一项全球人口研究中,有11%的英国成年人报告了CRS症状。关于是否应将抗生素纳入基本医疗管理的准则相互矛盾,反映出系统评价中缺乏证据。没有足够的证据来说明手术的作用,导致英国干预率的五倍变化。该试验的目的是在症状改善和国家卫生服务与标准医疗相比的成本方面,确定内镜鼻窦手术(ESS)或延长疗程的抗生素(克拉霉素)在成年CRS患者中的相对有效性(鼻内用药)6个月。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号